These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 33211435)

  • 1. [COVID-19 and asthma].
    Louis R; Calmes D; Frix AN; Schleich F
    Rev Med Liege; 2020 Sup; 75(S1):130-132. PubMed ID: 33211435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the COVID-19 pandemic in children with allergic asthma.
    Ruano FJ; Somoza Álvarez ML; Haroun-Díaz E; Vázquez de la Torre M; López González P; Prieto-Moreno A; Torres Rojas I; Cervera García MD; Pérez Alzate D; Blanca-López N; Canto Díez G
    J Allergy Clin Immunol Pract; 2020 Oct; 8(9):3172-3174.e1. PubMed ID: 32730834
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 and Asthma: Reflection During the Pandemic.
    Liu S; Zhi Y; Ying S
    Clin Rev Allergy Immunol; 2020 Aug; 59(1):78-88. PubMed ID: 32468411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 in a patient with severe asthma treated with Omalizumab.
    Lommatzsch M; Stoll P; Virchow JC
    Allergy; 2020 Oct; 75(10):2705-2708. PubMed ID: 32544254
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19.
    Chhiba KD; Patel GB; Vu THT; Chen MM; Guo A; Kudlaty E; Mai Q; Yeh C; Muhammad LN; Harris KE; Bochner BS; Grammer LC; Greenberger PA; Kalhan R; Kuang FL; Saltoun CA; Schleimer RP; Stevens WW; Peters AT
    J Allergy Clin Immunol; 2020 Aug; 146(2):307-314.e4. PubMed ID: 32554082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of COVID-19 on Patient-Initiated Discontinuation of Omalizumab in Two Academic Hospital Clinics at the University of Toronto.
    Seung Kim JH; Georgakopoulos JR; Yeung J
    J Cutan Med Surg; 2020; 24(5):534-535. PubMed ID: 33023343
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19-related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids.
    Peters MC; Sajuthi S; Deford P; Christenson S; Rios CL; Montgomery MT; Woodruff PG; Mauger DT; Erzurum SC; Johansson MW; Denlinger LC; Jarjour NN; Castro M; Hastie AT; Moore W; Ortega VE; Bleecker ER; Wenzel SE; Israel E; Levy BD; Seibold MA; Fahy JV
    Am J Respir Crit Care Med; 2020 Jul; 202(1):83-90. PubMed ID: 32348692
    [No Abstract]   [Full Text] [Related]  

  • 8. Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation.
    Beurnier A; Jutant EM; Jevnikar M; Boucly A; Pichon J; Preda M; Frank M; Laurent J; Richard C; Monnet X; Duranteau J; Harrois A; Chaumais MC; Bellin MF; Noël N; Bulifon S; Jaïs X; Parent F; Seferian A; Savale L; Sitbon O; Montani D; Humbert M
    Eur Respir J; 2020 Nov; 56(5):. PubMed ID: 32732333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asthma and COVID-19: an update.
    Adir Y; Saliba W; Beurnier A; Humbert M
    Eur Respir Rev; 2021 Dec; 30(162):. PubMed ID: 34911694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of coronavirus disease 2019 in a patient with asthma.
    Joshi AY; Mullakary RM; Iyer VN
    Allergy Asthma Proc; 2020 Jul; 41(4):296-300. PubMed ID: 32605700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma, biologics, corticosteroids, and coronavirus disease 2019.
    Akenroye AT; Wood R; Keet C
    Ann Allergy Asthma Immunol; 2020 Jul; 125(1):12-13. PubMed ID: 32387535
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence.
    Adir Y; Humbert M; Saliba W
    J Allergy Clin Immunol; 2021 Aug; 148(2):361-367.e13. PubMed ID: 34144110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of COVID-19-exacerbated asthma: should systemic corticosteroids be used?
    Kumar K; Hinks TSC; Singanayagam A
    Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1244-L1247. PubMed ID: 32401670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment and management of adults with asthma during the covid-19 pandemic.
    Beaney T; Salman D; Samee T; Mak V
    BMJ; 2020 Jun; 369():m2092. PubMed ID: 32513811
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial Effect of Inhaled Corticosteroids?
    Maes T; Bracke K; Brusselle GG
    Am J Respir Crit Care Med; 2020 Jul; 202(1):8-10. PubMed ID: 32437628
    [No Abstract]   [Full Text] [Related]  

  • 16. Common concerns in managing bronchial asthma during the COVID-19 pandemic.
    Chai CS; Liam CK
    Int J Tuberc Lung Dis; 2020 Jul; 24(7):750-752. PubMed ID: 32718416
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of inhaled corticosteroids in asthma and coronavirus disease 2019: Keep calm and carry on.
    Lipworth B; Chan R; Kuo CR
    Ann Allergy Asthma Immunol; 2020 Nov; 125(5):503-504. PubMed ID: 32585180
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drugs that aggravate the course of COVID-19 : really ?].
    Rothuizen LE; Livio F; Buclin T
    Rev Med Suisse; 2020 Apr; 16(N° 691-2):852-854. PubMed ID: 32348052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled corticosteroids and COVID-19-related mortality: confounding or clarifying?
    Singh D; Halpin DMG
    Lancet Respir Med; 2020 Nov; 8(11):1065-1066. PubMed ID: 32979985
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe asthma during the COVID-19 pandemic: Clinical observations.
    Haroun-Díaz E; Vázquez de la Torre M; Ruano FJ; Somoza Álvarez ML; Alzate DP; González PL; Prieto-Moreno A; Rojas IT; Cervera García MD; Blanca-López N; Díez GC
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2787-2789. PubMed ID: 32599217
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.